ZA83955B - Ergot alkaloids - Google Patents
Ergot alkaloidsInfo
- Publication number
- ZA83955B ZA83955B ZA83955A ZA83955A ZA83955B ZA 83955 B ZA83955 B ZA 83955B ZA 83955 A ZA83955 A ZA 83955A ZA 83955 A ZA83955 A ZA 83955A ZA 83955 B ZA83955 B ZA 83955B
- Authority
- ZA
- South Africa
- Prior art keywords
- ergot alkaloids
- ergot
- alkaloids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH89382 | 1982-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA83955B true ZA83955B (en) | 1984-09-26 |
Family
ID=4197630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA83955A ZA83955B (en) | 1982-02-12 | 1983-02-11 | Ergot alkaloids |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS58148888A (en) |
BE (1) | BE895842A (en) |
FR (1) | FR2528850B1 (en) |
HU (1) | HU187003B (en) |
SU (1) | SU1189351A3 (en) |
ZA (1) | ZA83955B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3649599A (en) * | 1998-04-16 | 1999-11-01 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Salivary prolactin test for serotonergic activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH505102A (en) * | 1967-11-01 | 1971-03-31 | Sandoz Ag | New ergot alkaloids |
US3891652A (en) * | 1973-06-28 | 1975-06-24 | Squibb & Sons Inc | Antianginal aryldecahydropyrrolo{8 3,4-f{9 quinolines |
CH602765A5 (en) * | 1974-09-27 | 1978-07-31 | Sandoz Ag |
-
1983
- 1983-02-08 BE BE1/10720A patent/BE895842A/en unknown
- 1983-02-10 JP JP58021396A patent/JPS58148888A/en active Granted
- 1983-02-11 HU HU83474A patent/HU187003B/en not_active IP Right Cessation
- 1983-02-11 SU SU833554752A patent/SU1189351A3/en active
- 1983-02-11 ZA ZA83955A patent/ZA83955B/en unknown
- 1983-08-05 FR FR838313067A patent/FR2528850B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2528850B1 (en) | 1985-07-26 |
JPS58148888A (en) | 1983-09-05 |
FR2528850A1 (en) | 1983-12-23 |
SU1189351A3 (en) | 1985-10-30 |
HU187003B (en) | 1985-10-28 |
JPH0352473B2 (en) | 1991-08-12 |
BE895842A (en) | 1983-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8311973D0 (en) | Quinoline derivatives | |
DE3377796D1 (en) | Quinoline derivatives | |
ZA833008B (en) | Ergoline derivatives | |
GB2125041B (en) | Ergot alkaloids | |
AU553514B2 (en) | Vinca alkaloids | |
PH21234A (en) | Ergot alkaloids | |
PT72785A (en) | Ergoline derivatives | |
GB2115811B (en) | Ergot alkaloids | |
GB2074566B (en) | Ergoline derivatives | |
GB2092570B (en) | Ergot alkaloids | |
ZA812103B (en) | Ergoline derivatives | |
NZ189422A (en) | Ergot peptide alkaloids | |
ZA83955B (en) | Ergot alkaloids | |
GB2094798B (en) | Ergot alkaloids | |
PH20160A (en) | Ergoline derivatives | |
JPS57159783A (en) | Manufacture of ergot alkaloids | |
GB2131674B (en) | Ashtray | |
IE802091L (en) | Ergot peptide alkaloids | |
GB2135307B (en) | Ergot derivatives | |
KR840000329Y1 (en) | Ashtray | |
KR860000957Y1 (en) | Ashtray | |
GB8312447D0 (en) | Ergot derivatives | |
ZA841150B (en) | Ergot derivatives | |
IE822659L (en) | Morphinane derivatives | |
IE820346L (en) | Quinoline derivatives |